Details for 2018179796

Up to date per 04.04.2026

Actions

Title / Product Name

FORMULIERUNG ZUR HIV-BEHANDLUNG AUS ATAZANAVIR UND COBICISTAT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018179796

EP Publication Number

3421033

E-Number

1506597

Language

PCT Number

Publication Date

02.01.2019 A

27.07.2022 B1

Registration Date

27.07.2022

AT Publication Date

15.08.2022

Application Date

06.10.2014

Registration Number

Priorities

07.10.2013

201361887574 P

IPC

A61K 9/24 20060101AFI20220315BHEP

Maximum Duration of Protection

06.10.2034

Owner

Bristol-Myers Squibb Holdings Ireland Unlimited CompanyHinterbergstrasse 16 6312 SteinhausenCH

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

KOO, Otilia May Yuec/o Bristol-Myers Squibb Company 1 Squibb Drive New Brunswick, New Jersey 08903US

NIKFAR, Faranakc/o Bristol-Myers Squibb Company 1 Squibb Drive New Brunswick, New Jersey 08903US

TAO, Jingc/o Bristol-Myers Squibb Company 1 Squibb Drive New Brunswick, New Jersey 08903US

KOTTALA, Niranjan KumarFlat 502 PVR Grand Apt. Simon Nagar Kurmannapalem AP 530056 VisakhapatnamIN

VARIA, Sailesh A.c/o Bristol-Myers Squibb Company 1 Squibb Drive New Brunswick, New Jersey 08903US

Information about Fees